| NMPA公布参比制剂 |
|---|
| 序号 |
药品通用名 |
英文名称 |
商标名 |
规格 |
剂型 |
持证商 |
备注 |
| 27-185 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin |
500mg/100mg |
注射剂 |
Beechamgroup Ltd |
未进口原研药品 |
| 27-186 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin |
1000mg/200mg |
注射剂 |
Beechamgroup Ltd |
未进口原研药品 |
| 27-175 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin |
500mg/100mg |
注射剂 |
Beechamgroup Ltd |
未进口原研药品 |
| 27-176 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin |
1000mg/200mg |
注射剂 |
Beechamgroup Ltd |
未进口原研药品 |
| 32-39 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
550mg(500/50) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 32-40 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
1.1g(1000/100) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 32-41 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
2.2g(2000/200) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 32-71 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
550mg(500/50) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 32-72 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
1.1g(1000/100) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 32-73 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for injection(10:1) |
|
2.2g(2000/200) |
注射剂 |
GlaxoSmithKline AG |
未进口原研药品 |
| 27-176 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin/Levmentin |
1000mg/200mg |
注射剂 |
Beechamgroup Ltd/Laboratoires Delbert |
未进口原研药品 |
| 27-176 |
注射用阿莫西林钠克拉维酸钾 |
Amoxicillin Sodium and Clavulanate Potassium for Injection |
Augmentin/Levmentin |
1000mg/200mg |
注射剂 |
Beechamgroup Ltd/Laboratoires Delbert |
未进口原研药品 |
